Skip to content

ReWrite

Your desired genetic code with our expert stem cell genome editing services

We accelerate your research by providing iPSC Generation & Genome Editing Services

The Bio-Incubator Leuven building, home of ReWrite’s lab

Who we are

ReWrite is an independent start-up founded by scientists from the Stem Cell Institute Leuven

Our founder and our CSO built their expertise at the Stem Cell Institute Leuven (SCIL), founded in 2005 at KU Leuven, where they spent years reprogramming and genome editing human stem cells. ReWrite brings that experience to your lab, with the enthusiasm and entrepreneurial spirit of a dedicated team led by Prof. em. Catherine Verfaillie and spearheaded by Dr. Arefe Nami.

Find out more

Why ReWrite is a trusted choice

  • Expert-driven, efficient and affordable; scientists with years of hands-on experience.
  • Streamlined process with minimum time-to-results.
  • Comprehensive quality control; genomic integrity, pluripotency, off-target analysis and more.
  • Consistent and reliable outcomes; with intermediate reports along the way.
  • Tailored to your needs based on deep scientific discussions.
A ReWrite scientist working in a biosafety cabinet

Outstanding track record of ReWrite scientists

(performed at the Stem Cell Institute Leuven)

studies demonstrating our expertiseSee selected publications
+41
genetically edited stem cells
+106
reprogrammed iPSC lines
+62

How we work

From first call to validated cells

Full process & FAQ
  1. 01Free consultationWe discuss your model, the edit you need and how you will read it out.
  2. 02Design & quoteStrategy, QC package and timeline, agreed in writing.
  3. 03Reprogramming & editingIntermediate reports keep you informed of progress.
  4. 04QC & deliveryValidated lines shipped with full documentation.

Project FIT: Muscle Stem Cell Therapy

Within the Euregio Meuse-Rhine, ReWrite is collaborating with leading universities and innovative companies on Project FIT (IMR6-00132). We are advancing personalised therapies using patient-derived muscle stem cells to treat rare disorders, age-related muscle loss, and heart diseases.

This initiative brings together expertise from Maastricht, Leuven, Liège, Hasselt, and Aachen to deliver high-quality, affordable treatments for conditions where effective options are currently lacking.

Project co-funded by the European Union and the Walloon Region.

Project FIT – Interreg Euregio Meuse-Rhine, co-funded by the European Union

Publications

Selected work of our scientists

All publications

Research performed at the Stem Cell Institute Leuven (all rights belong to KU Leuven) by scientists who are now part of ReWrite.

Planning an iPSC or genome editing project?

Tell us what you need – we are happy to discuss your project.